Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Patients should be educated about the importance of maintaining treatment adherence, as discontinuation leads to recurrent deficiency within months to years
A rare complication of this deficiency is optic neuropathy which results in progressive, bilateral, painless vision loss
PubMed laboratory research record [PMID: 4818431] PubMed record related to this compound for laboratory literature review
Clinical Applications While human trials are limited and 5-Amino-1MQ is not FDA-approved as a therapeutic agent, its mechanism and early research suggest potential benefits in: Weight management and body recomposition Adiposity reduction and fat loss Insulin sensitivity improvement Metabolic syndrome support NAD optimization and anti-aging protocols Cellular energy and endurance enhancement Adjunct to exercise or caloric restriction protocols It may be particularly relevant for individuals with stubborn fat loss resistance , age-related metabolic decline, or those using NAD-supportive therapies like NMN or NR
US$ 27.45
US$ 24.15
US$ 21.40
US$ 27.04
US$ 26.37
US$ 21.00
US$ 23.81
.png.jpg)
US$ 28.60
